In the news

News headlines are articles that reference ResMed's company, people, or business practices.

Advanced Search
  • April 3, 2018
    Medical Design & Outsourcing

    One company, ResMed (NYSE: RMD), has taken on the challenge of helping users become more compliant, the ecosystem more cost-effective and customers more loyal through a model of connected health. San Diego–based ResMed’s quest to improve patient compliance began over a decade ago, explained CEO Mick Farrell. “We started our first digital health experiments with UC San Diego in 2002 and learned a lot over a decade.”

  • February 21, 2018
    CommonWell Alliance

    Why did we at Brightree embrace FHIR for our connectivity with CommonWell and other portions of our interoperability solutions sets? We are writing today to help folks understand how we view FHIR fitting into the post-acute interoperability world and our interoperability commitment.

  • February 7, 2018
    News release

    The GEMCO-Brightree partnership simplifies the ordering process for DME/HME dealers by allowing them to place GEMCO orders directly from the Brightree Integrated ePurchasing platform. This streamlined process allows providers to reduce costs and increase revenue with no additional charge for integration.

  • January 19, 2018
    HomeCare

    “One of the greatest benefits of connected health is its ability to segment patient populations in the ways that will more efficiently help patients and their home care providers,” says Jeremy Malecha, VP of SaaS Strategy Development for ResMed. “Among sleep apnea patients, for instance, it’s crucial for HMEs to know how well their patients are adhering to PAP (positive airway pressure) therapy. When the right information is presented quickly and clearly, HMEs can more easily determine which patients need what types of support to improve health outcomes—and prioritize based on urgency and available resources.”

Show 5102550100 per page
Media contacts - Bottom Blue - All Interior Pages

Media contact

Jayme Rubenstein
(858) 836-6798

news@resmed.com

 

Receive ResMed news releases when they publish.

Subscribe

ResMed provides a non-transferable, non-exclusive license to the copyrighted images, drawings and materials subject to the following Terms of Use.

All countries & languages